MJA
MJA

Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions

Paul Langton, Graeme Hankey and John Eikelboom
Med J Aust 2005; 182 (4): . || doi: 10.5694/j.1326-5377.2005.tb06658.x
Published online: 21 February 2005

Paul Langton,* Graeme Hankey, John Eikelboom

Online responses are no longer available. Please refer to our instructions for authors page for more information.